跳至主要内容
临床试验/ACTRN12619000742178
ACTRN12619000742178招募中未知

Effect of automated control of oxygen administration on oxygen saturation targeting in term newborns and young infants requiring mechanical respiratory support and oxygen therapy

Murdoch Childrens Research Institute0 个研究点目标入组 70 人开始时间: 2019年5月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 9 Months(—)
性别
All

入选标准

  • Term newborns with hypoxic respiratory failure, and young infants with respiratory insufficiency related to respiratory tract infection, fulfilling the eligibility criteria outlined below.
  • Participants will be assigned to a randomised trial treatment only if they meet all of the inclusion criteria and none of the exclusion criteria.
  • Inclusion criteria
  • Each participant must meet all of the following criteria in either study population (‘Study group A’ or Study group B’) to be enrolled in the study.
  • Study group A: Term and near-term infants requiring mechanical respiratory support and oxygen therapy of any duration due to hypoxic respiratory failure (HRF).
  • Gestation at birth greater than or equal to 35 completed weeks.
  • Chronological age less than or equal to 2 months.
  • HRF related to any of parenchymal lung disease, neonatal acute respiratory distress syndrome, pulmonary hypertension or diaphragmatic hernia
  • Receiving non-invasive respiratory support (CPAP and HFNC), or intubated and mechanically ventilated using any of the modes available with the SLE6000 ventilator.
  • Study group B: Young infants requiring non-invasive or invasive mechanical respiratory support and supplemental oxygen therapy of any duration secondary to RTI.
  • Any gestation at birth.
  • Chronological age less than or equal to 9 months and corrected gestational age less than or equal to 6 months
  • Respiratory insufficiency due to respiratory tract infection (viral or bacterial)
  • Receiving non-invasive respiratory support (CPAP and HFNC), or intubated and mechanically ventilated using any of the modes available with the SLE6000 ventilator.
  • For participants in both groups, the following inclusion criteria must be met:
  • Supplemental oxygen therapy being administered at study entry (baseline oxygen requirement at least 30%).
  • SLE6000 ventilator with OxyGenie® option available for the study.
  • Research team available to commence recording.
  • Agreement of treating clinicians that the participant is appropriate for study.

排除标准

  • Exclusion criteria (common to both study groups):
  • Cardiorespiratory instability that precludes entry into a study.
  • Change in mode of respiratory support anticipated in next 24 hours.

研究者

相似试验